Only 45% of Patients Talk to Providers About Statin Challenges
Free Peer-reviewed Study Sponsored by Kowa
To understand why people stop taking statins, a life-saving medication, despite the serious risks of high cholesterol Kowa Pharmaceuticals commissioned ACTION: The Statin Survey (Understanding Patient Adherence and Concerns with Statins, and Medication Discussions with Physicians) with Harris Poll of more than 5,000 Americans aged 45+ who have been diagnosed with high cholesterol and have ever used a statin to treat high cholesterol. By shedding additional light on the cholesterol patient mindset, and identifying knowledge gaps, Kowa Pharmaceuticals American, Inc. seeks to support a more productive dialogue between providers and patients that ultimately helps patients stick with a statin that fits their individualized needs.
Below, you can click to download a handy fact sheet infographic highlighting results from this survey, which may be useful during conversations with your patients. You may also wish to direct patients to Kowa Pharmaceuticals’ new online patient resource, “Take Cholesterol to Heart,” which encourages patients to speak frankly to their provider about their personal challenges staying on statin therapy so they can develop strategies to stick with their medication.
ACTION: The Statin Survey Method Statement
Harris Poll conducted ACTION: The Statin Survey on behalf of Kowa Pharmaceuticals America, Inc., within the United States from July 7- August 4, 2017, among 5,014 U.S. adults aged 45 or older, who have been diagnosed with high cholesterol, and have ever used a statin to treat high cholesterol. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Erin Bittner at W2O Group, 212-301-7226.
1Data on file: ACTION: The Statin Survey
2 1 Cohen JD, et al. Understanding statin use in America and gaps in patient education (USAGE): An internet-based survey of 10,138 current and former statin users. Journal of Clinical Lipidology. 2012; 6, 208-215
The posting of sponsored information and content on this page should not be considered an AAFP endorsement or recommendation of the sponsor's products, services, policies, or procedures. The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods, or services.